Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Blood Ratio Test to Predict Heart Problems in Acute Coronary Syndrome

Studies whether a blood ratio predicts heart events in adults with acute coronary syndrome.

Plain-language title generated from the registry record
Registry title: High Sensitive C-reactive Protein to Albumin Ratio in Acute Coronary Syndrome

Key facts

Where
Sohag, EgyptSee the site

Where in Egypt

  • Sohag faculty of medicineSohag, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Sohag University
Trial code
NCT06673381
Record updated
4 November 2024
Original description
assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patientsRead full original descriptionShow less

Prediction of Acute Coronary Syndrome In-hospital Major Adverse Cardiovascular Events by High Sensitivity C- Reactive Protein to Albumin Ratio

assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients

Inclusion: All patients aged 18 Year or older presented by ACS not candidet for primary percutaneus coronary intervention ( PCI ) .

Exclusion: • Patients aged < 18 years old; Patients who have eGFR <60 ml/kg /m2; Patients who have malignancies; Patients who have chronic heart failure (NYHA class >II); Pateints who have chronic liver disease; Patients who have nephrotic syndrome; Patients who have acute cerebrovascular stroke; Pregnant women; Patients who have recent infection.

ClinicalTrials.gov NCT06673381